How to design a dose-finding study using the continual reassessment method

INTRODUCTION: The continual reassessment method (CRM) is a model-based design for phase I trials, which aims to find the maximum tolerated dose (MTD) of a new therapy. The CRM has been shown to be more accurate in targeting the MTD than traditional rule-based approaches such as the 3 + 3 design, whi...

Descripción completa

Detalles Bibliográficos
Autores principales: Wheeler, Graham M., Mander, Adrian P., Bedding, Alun, Brock, Kristian, Cornelius, Victoria, Grieve, Andrew P., Jaki, Thomas, Love, Sharon B., Odondi, Lang’o, Weir, Christopher J., Yap, Christina, Bond, Simon J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Technical Advance
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339349/
https://www.ncbi.nlm.nih.gov/pubmed/30658575
http://dx.doi.org/10.1186/s12874-018-0638-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339349/
https://www.ncbi.nlm.nih.gov/pubmed/30658575
http://dx.doi.org/10.1186/s12874-018-0638-z

Ejemplares similares